Key result
AWGC-defined cachexia affects ~25% of older HF patients and independently predicts increased mortality.
Why the study?
Does the presence of cachexia predict all-cause and cardiovascular death in older adults with heart failure?
Cohort
Does the presence of cachexia predict all-cause and cardiovascular death in older adults with heart failure?
Answers are grounded in this paper and cite their sources.
Cachexia diagnosed by the AWGC 2023 criteria is highly prevalent in older heart failure patients and independently predicts all-cause and cardiovascular mortality.
BACKGROUND: Few studies have examined the characteristics of heart failure (HF) patients with cachexia using the Asian Working Group for Cachexia (AWGC) 2023 criteria. This study assessed the characteristics and clinical impact of cachexia in older adults with HF. METHODS AND RESULTS: Results of laboratory measurements, echocardiography, physical function, depression, nutritional status, and the prevalence of cachexia, frailty, and sarcopenia were assessed in older adults (≥65 years) with HF in a stable condition just before discharge. After discharge, all participants were prospectively followed for adverse clinical events. Patients were classified based on the presence or absence of cachexia, and their frailty, sarcopenia, and clinical outcomes were compared. The prevalence of cachexia diagnosed by AWGC 2023 and Evans criteria was 24.7% and 12.9%, respectively. Among HF patients with cachexia, 71.6% had frailty and 86.7% had sarcopenia. Patients with cachexia had significantly poorer physical function and nutrition than those without. Cox proportional hazards analysis identified cachexia as an independent predictor of all-cause and cardiovascular death. CONCLUSIONS: Cachexia in older adults with HF is strongly associated with poor physical function, malnutrition, and adverse clinical outcomes. Early identification and management of cachexia may help improve the prognosis in this population.
No takes yet. Share an insight, caveat, or question.
Hashimoto et al. (2025) conducted a cohort in Heart failure. Cachexia vs. Absence of cachexia was evaluated on All-cause and cardiovascular death. Cachexia diagnosed by AWGC 2023 criteria was present in 24.7% of older adults with heart failure and was an independent predictor of all-cause and cardiovascular death.
Synapse has enriched 10 related papers. Consider them for comparative context: